147 related articles for article (PubMed ID: 21323741)
1. Nuclear β-catenin expression in basal cell adenomas of salivary gland.
Kawahara A; Harada H; Abe H; Yamaguchi T; Taira T; Nakashima K; Mihashi H; Akiba J; Kage M
J Oral Pathol Med; 2011 Jul; 40(6):460-6. PubMed ID: 21323741
[TBL] [Abstract][Full Text] [Related]
2. Distinctive Patterns of CTNNB1 (β-Catenin) Alterations in Salivary Gland Basal Cell Adenoma and Basal Cell Adenocarcinoma.
Jo VY; Sholl LM; Krane JF
Am J Surg Pathol; 2016 Aug; 40(8):1143-50. PubMed ID: 27259009
[TBL] [Abstract][Full Text] [Related]
3. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
4. Expression of betacatenin in carcinoma in pleomorphic adenoma, pleomorphic adenoma and normal salivary gland: an immunohistochemical study.
do Prado RF; Consolaro A; Taveira LA
Med Oral Patol Oral Cir Bucal; 2006 May; 11(3):E247-51. PubMed ID: 16648762
[TBL] [Abstract][Full Text] [Related]
5. CTNNB1 mutations in basal cell adenoma of the salivary gland.
Lee YH; Huang WC; Hsieh MS
J Formos Med Assoc; 2018 Oct; 117(10):894-901. PubMed ID: 29224720
[TBL] [Abstract][Full Text] [Related]
6. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
[TBL] [Abstract][Full Text] [Related]
7. β-catenin (CTNNB1) S33C mutation in ovarian microcystic stromal tumors.
Maeda D; Shibahara J; Sakuma T; Isobe M; Teshima S; Mori M; Oda K; Nakagawa S; Taketani Y; Ishikawa S; Fukayama M
Am J Surg Pathol; 2011 Oct; 35(10):1429-40. PubMed ID: 21881488
[TBL] [Abstract][Full Text] [Related]
8. Infarction of basal cell adenoma of the parotid gland: First case report and literature review on CTNNB1 I35T mutations in salivary basal cell neoplasms.
Oh KY; Hong SD
Oral Oncol; 2023 Oct; 145():106534. PubMed ID: 37517215
[TBL] [Abstract][Full Text] [Related]
9. Difference in transducin-like enhancer of split 1 protein expression between basal cell adenomas and basal cell adenocarcinomas - an immunohistochemical study.
Oyama Y; Nishida H; Kusaba T; Kadowaki H; Arakane M; Wada J; Urabe S; Hirano T; Kawano K; Suzuki M; Yokoyama S; Daa T
Diagn Pathol; 2018 Jul; 13(1):48. PubMed ID: 30053869
[TBL] [Abstract][Full Text] [Related]
10. Nuclear beta-catenin in basal cell adenomas.
do Prado RF; Cardoso CL; Consolaro A; de Assis Taveira LA
Int J Surg Pathol; 2007 Apr; 15(2):219-20. PubMed ID: 17478787
[No Abstract] [Full Text] [Related]
11. Paneth cell differentiation in colonic epithelial neoplasms: evidence for the role of the Apc/beta-catenin/Tcf pathway.
Joo M; Shahsafaei A; Odze RD
Hum Pathol; 2009 Jun; 40(6):872-80. PubMed ID: 19269007
[TBL] [Abstract][Full Text] [Related]
12. Beta-catenin and E-cadherin expression in salivary gland tumors.
Furuse C; Cury PR; Altemani A; dos Santos Pinto D; de Araújo NS; de Araújo VC
Int J Surg Pathol; 2006 Jul; 14(3):212-7. PubMed ID: 16959701
[TBL] [Abstract][Full Text] [Related]
13. Mutations and nuclear accumulation of beta-catenin correlate with intestinal phenotypic expression in human gastric cancer.
Ogasawara N; Tsukamoto T; Mizoshita T; Inada K; Cao X; Takenaka Y; Joh T; Tatematsu M
Histopathology; 2006 Dec; 49(6):612-21. PubMed ID: 17163846
[TBL] [Abstract][Full Text] [Related]
14. Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.
Bonnet S; Gaujoux S; Launay P; Baudry C; Chokri I; Ragazzon B; Libé R; René-Corail F; Audebourg A; Vacher-Lavenu MC; Groussin L; Bertagna X; Dousset B; Bertherat J; Tissier F
J Clin Endocrinol Metab; 2011 Feb; 96(2):E419-26. PubMed ID: 21084400
[TBL] [Abstract][Full Text] [Related]
15. Using a combination of cytochrome P450 1B1 and beta-catenin for early diagnosis and prevention of colorectal cancer.
Chang H; Su JM; Huang CC; Liu LC; Tsai CH; Chou MC; Lin P
Cancer Detect Prev; 2005; 29(6):562-9. PubMed ID: 16289386
[TBL] [Abstract][Full Text] [Related]
16. A comparative analysis of LEF-1 in odontogenic and salivary tumors.
Bilodeau EA; Acquafondata M; Barnes EL; Seethala RR
Hum Pathol; 2015 Feb; 46(2):255-9. PubMed ID: 25497834
[TBL] [Abstract][Full Text] [Related]
17. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.
Kim HS; Hong EK; Park SY; Kim WH; Lee HS
Anticancer Res; 2003; 23(3C):2863-8. PubMed ID: 12926124
[TBL] [Abstract][Full Text] [Related]
18. C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):586-93. PubMed ID: 12738950
[TBL] [Abstract][Full Text] [Related]
19. Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas.
Cetani F; Pardi E; Banti C; Collecchi P; Viacava P; Borsari S; Fanelli G; Naccarato AG; Saponaro F; Berti P; Miccoli P; Pinchera A; Marcocci C
Endocr Relat Cancer; 2010 Mar; 17(1):1-6. PubMed ID: 19755524
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas.
Ikeda S; Ishizaki Y; Shimizu Y; Fujimori M; Ojima Y; Okajima M; Sugino K; Asahara T
Int J Oncol; 2002 Mar; 20(3):463-6. PubMed ID: 11836555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
